Brokx S J, Talbot J, Georges F, Waygood E B
Department of Biochemistry, Health Science Building, University of Saskatchewan, Canada.
Biochemistry. 2000 Apr 4;39(13):3624-35. doi: 10.1021/bi991250z.
Enzyme I mutants of the Salmonella typhimurium phosphoenolpyruvate:sugar phosphotransferase system (PTS), which show in vitro intragenic complementation, have been identified as Arg126Cys (strain SB1690 ptsI34), Gly356Ser (strain SB1681 ptsI16), and Arg375Cys (strain SB1476 ptsI17). The mutation Arg126Cys is in the N-terminal HPr-binding domain, and complements Gly356Ser and Arg375Cys enzyme I mutations located in the C-terminal phosphoenolpyruvate(PEP)-binding domain. Complementation results in the formation of unstable heterodimers. None of the mutations alters the K(m) for HPr, which is phosphorylated by enzyme I. Arg126 is a conserved residue; the Arg126Cys mutation gives a V(max) of 0.04% wild-type, establishing a role in phosphoryl transfer. The Gly356Ser and Arg375Cys mutations reduce enzyme I V(max) to 4 and 2%, respectively, and for both, the PEP K(m) is increased from 0.1 to 3 mM. It is concluded that this activity was from the monomer, rather than the dimer normally found in assays of wild-type. In the presence of Arg126Cys enzyme, V(max) for Gly356Ser and Arg375Cys enzymes I increased 6- and 2-fold, respectively; the K(m) for PEP decreased to <10 microM, but the K(m) became dependent upon the stability of the heterodimer in the assay. Gly356 is conserved in enzyme I and pyruvate phosphate dikinase, which is a homologue of enzyme I, and this residue is part of a conserved sequence in the subunit interaction site. Gly356Ser mutation impairs enzyme I dimerization. The mutation Arg375Cys also impairs dimerization, but the equivalent residue in pyruvate phosphate dikinase is not associated with the subunit interaction site. A 37 000 Da, C-terminal domain of enzyme I has been expressed and purified; it dimerizes and complements Gly356Ser and Arg375Cys enzymes I proving that the association/dissociation properties of enzyme I are a function of the C-terminal domain.
糖磷酸转移酶系统(PTS)的酶I突变体在体外表现出基因内互补,已鉴定出这些突变体为精氨酸126位突变为半胱氨酸(菌株SB1690 ptsI34)、甘氨酸356位突变为丝氨酸(菌株SB1681 ptsI16)和精氨酸375位突变为半胱氨酸(菌株SB1476 ptsI17)。精氨酸126位突变为半胱氨酸的突变位于N端HPr结合结构域,可与位于C端磷酸烯醇丙酮酸(PEP)结合结构域的甘氨酸356位突变为丝氨酸和精氨酸375位突变为半胱氨酸的酶I突变体互补。互补导致形成不稳定的异二聚体。这些突变均未改变被酶I磷酸化的HPr的K(m)值。精氨酸126是一个保守残基;精氨酸126位突变为半胱氨酸的突变体的V(max)为野生型的0.04%,这表明其在磷酸转移中起作用。甘氨酸356位突变为丝氨酸和精氨酸375位突变为半胱氨酸的突变分别将酶I的V(max)降低至4%和2%,并且对于这两种突变体,PEP的K(m)值从0.1 mM增加到3 mM。得出的结论是,这种活性来自单体,而不是野生型测定中通常发现的二聚体。在存在精氨酸126位突变为半胱氨酸的酶的情况下,甘氨酸356位突变为丝氨酸和精氨酸375位突变为半胱氨酸的酶I的V(max)分别增加了6倍和2倍;PEP的K(m)值降至<10 microM,但K(m)值变得依赖于测定中异二聚体的稳定性。甘氨酸356在酶I和丙酮酸磷酸二激酶(酶I的同源物)中是保守的,该残基是亚基相互作用位点中保守序列的一部分。甘氨酸356位突变为丝氨酸的突变损害了酶I的二聚化。精氨酸375位突变为半胱氨酸的突变也损害了二聚化,但丙酮酸磷酸二激酶中的等效残基与亚基相互作用位点无关。已表达并纯化了一个37000 Da的酶I C端结构域;它形成二聚体并与甘氨酸356位突变为丝氨酸和精氨酸375位突变为半胱氨酸的酶I互补,证明酶I的缔合/解离特性是C端结构域的功能。